Bookmark and Share
Camptothecin (CID 24360) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(1594)
 
 
Inactive(671)
 
 
Inconclusive(189)
 
 
Unspecified(840)
 
 
Top Targets:
Topoisomer IB..(86)
 
 
 
 
7TM GPCR Srx(36)
 
 
 
 
p450(29)
 
 
 
 
 
7TM GPCR Srsx(26)
 
 
 
 
PLN02808(13)
 
 
 
BioAssay Types:
Literature(1426)
 
 
 
 
 
Confirmatory(1364)
 
 
 
 
 
Screening(203)
 
 
 
 
Summary(1)
 
 
BioActivity Types:
IC50(1277)
 
 
 
 
 
Potency(453)
 
 
 
 
 
EC50(29)
 
 
 
 
Kd(3)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 2952    Data Row: 3294   Total Pages: 165   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103168388]
IC50 4e-06Cytotoxicity against human RPMI-8240 cells [AID331450, Type: Literature]
View
2
[SID103168388]
IC50 4e-06Cytotoxicity against human P388 cells [AID331452, Type: Literature]
View
3
[SID103168388]
IC50 2.54e-05SANGER: Inhibition of human ES7 cell growth in a cell viability assay. [AID742151, Type: confirmatory]
View
4
[SID103168388]
IC50 4e-05Cytotoxicity against human MOLT4 cells after 72 hrs by MTT assay [AID760278, Type: confirmatory]
View
5
[SID103168388]
IC50 4.84e-05SANGER: Inhibition of human NCI-H209 cell growth in a cell viability assay. [AID741726, Type: confirmatory]
View
6
[SID103168388]
IC50 9.57e-05SANGER: Inhibition of human ES1 cell growth in a cell viability assay. [AID742146, Type: confirmatory]
View
7
[SID103168388]
IC50 0.000102SANGER: Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay. [AID741802, Type: confirmatory]
View
8
[SID103168388]
IC50 0.000121SANGER: Inhibition of human EW-16 cell growth in a cell viability assay. [AID742160, Type: confirmatory]
View
9
[SID103168388]
IC50 0.000129SANGER: Inhibition of human MHH-ES-1 cell growth in a cell viability assay. [AID742360, Type: confirmatory]
View
10
[SID103168388]
IC50 0.000132SANGER: Inhibition of human D-566MG cell growth in a cell viability assay. [AID742109, Type: confirmatory]
View
11
[SID103168388]
IC50 0.00014SANGER: Inhibition of human BFTC-905 cell growth in a cell viability assay. [AID741977, Type: confirmatory]
View
12
[SID103168388]
EC50 0.00015Concentration required to inhibit growth of SW620 (human colon cancer) cells in the presence of 10 uM of Compound 2e [AID246473, Type: Literature]
View
13
[SID103168388]
IC50 0.000171SANGER: Inhibition of human 639-V cell growth in a cell viability assay. [AID741933, Type: confirmatory]
View
14
[SID103168388]
IC50 0.000182SANGER: Inhibition of human HSC-4 cell growth in a cell viability assay. [AID742225, Type: confirmatory]
View
15
[SID103168388]
IC50 0.000194SANGER: Inhibition of human NBsusSR cell growth in a cell viability assay. [AID742397, Type: confirmatory]
View
16
[SID103168388]
IC50 0.000212SANGER: Inhibition of human HT-3 cell growth in a cell viability assay. [AID742232, Type: confirmatory]
View
17
[SID103168388]
IC50 0.000271SANGER: Inhibition of human EoL-1-cell cell growth in a cell viability assay. [AID742166, Type: confirmatory]
View
18
[SID103168388]
IC50 0.000274SANGER: Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay. [AID741784, Type: confirmatory]
View
19
[SID103168388]
IC50 0.000319SANGER: Inhibition of human EW-3 cell growth in a cell viability assay. [AID742164, Type: confirmatory]
View
20
[SID103168388]
IC50 0.000358SANGER: Inhibition of human H9 cell growth in a cell viability assay. [AID742187, Type: confirmatory]
View